Jmac Enterprises LLC acquired a new position in DuPont de Nemours, Inc. (NYSE:DD – Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 4,300 shares of the basic materials company’s stock, valued at approximately $559,000.
A number of other large investors have also recently added to or reduced their stakes in the business. State Street Corp increased its holdings in DuPont de Nemours by 140.3% during the 2nd quarter. State Street Corp now owns 44,941,824 shares of the basic materials company’s stock valued at $6,095,909,000 after acquiring an additional 26,238,300 shares in the last quarter. Bank of America Corp DE lifted its holdings in shares of DuPont de Nemours by 22.0% in the first quarter. Bank of America Corp DE now owns 4,629,671 shares of the basic materials company’s stock valued at $212,039,000 after purchasing an additional 835,572 shares in the last quarter. Bank of New York Mellon Corp grew its position in shares of DuPont de Nemours by 10.0% in the first quarter. Bank of New York Mellon Corp now owns 3,706,596 shares of the basic materials company’s stock valued at $169,762,000 after purchasing an additional 336,780 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of DuPont de Nemours by 4.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,509,831 shares of the basic materials company’s stock worth $160,688,000 after purchasing an additional 163,210 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its stake in shares of DuPont de Nemours by 16.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 971,901 shares of the basic materials company’s stock worth $124,360,000 after purchasing an additional 137,070 shares in the last quarter. 73.96% of the stock is owned by institutional investors and hedge funds.
DuPont de Nemours News Summary
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Analysts raised their targets and kept bullish ratings. UBS lifted its target to $182 and maintained a Buy rating; Citigroup raised its target to $176 with a Buy rating; and Barclays raised its target to $176 with an Overweight rating. UBS rating information Citigroup rating information Barclays rating information
- Positive Sentiment: Q3 results beat expectations and growth was broad-based. DuPont reported adjusted EPS of $2.09 versus the $1.87 consensus and revenue of about $1.9 billion, up 4% year over year; organic sales increased 5%. The company cited strong healthcare and aerospace demand. Reuters report on DuPont’s outlook
- Positive Sentiment: DuPont raised its 2026 outlook and plans further buybacks. After exceeding its third-quarter guidance, the company increased its full-year guidance and announced plans to repurchase $250 million of shares in the fourth quarter, supporting the investment case. DuPont third-quarter results
- Neutral Sentiment: A new peptide-purification product could offer a growth opportunity, but the supplied article listing does not provide enough detail to assess its likely revenue contribution. Article on DuPont’s peptide-purification product
- Negative Sentiment: DD has softened after its earnings-related surge. The coverage provided does not point to a specific adverse catalyst, so the pullback may reflect profit-taking rather than a deterioration in the reported business outlook.
DuPont de Nemours Stock Performance
Shares of NYSE DD opened at $151.15 on Thursday. The company has a 50-day simple moving average of $132.93 and a 200-day simple moving average of $138.62. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.36 and a quick ratio of 1.82. The company has a market cap of $20.41 billion, a PE ratio of 67.78, a price-to-earnings-growth ratio of 1.37 and a beta of 1.06. DuPont de Nemours, Inc. has a 12 month low of $111.15 and a 12 month high of $157.98.
DuPont de Nemours (NYSE:DD – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.22. The business had revenue of $1.87 billion for the quarter, compared to the consensus estimate of $1.84 billion. DuPont de Nemours had a net margin of 4.26% and a return on equity of 6.85%. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.09 earnings per share. On average, equities analysts anticipate that DuPont de Nemours, Inc. will post 7.49 earnings per share for the current year.
DuPont de Nemours Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be issued a $0.60 dividend. The ex-dividend date is Monday, November 30th. This represents a $2.40 annualized dividend and a yield of 1.6%. DuPont de Nemours’s payout ratio is 533.33%.
Analyst Ratings Changes
DD has been the subject of several research reports. Royal Bank Of Canada cut their price objective on DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating for the company in a research report on Thursday, October 15th. UBS Group increased their target price on DuPont de Nemours from $172.00 to $182.00 and gave the company a “buy” rating in a report on Wednesday. The Goldman Sachs Group dropped their price target on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating for the company in a research report on Wednesday, September 30th. Barclays boosted their price target on DuPont de Nemours from $156.00 to $176.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Zacks Research downgraded DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 17th. Twelve research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $164.75.
View Our Latest Research Report on DD
DuPont de Nemours Company Profile
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Featured Articles
- Five stocks we like better than DuPont de Nemours
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
